Cargando…

Current understanding of tyrosine kinase BMX in inflammation and its inhibitors

Tec family kinases, which include tyrosine kinase expressed in hepatocellular carcinoma (TEC), Bruton’s tyrosine kinase (BTK), interleukin (IL)-2-inducible T-cell kinase (ITK), tyrosine-protein kinase (TXK), and bone marrow tyrosine kinase on chromosome X (BMX), are the second largest group of non-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Le, Wang, Fei, Liu, Sheng, Chen, Xu-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012028/ https://www.ncbi.nlm.nih.gov/pubmed/27602372 http://dx.doi.org/10.4103/2321-3868.135483

Ejemplares similares

The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma
por: Zhuang, Jintao, et al.
Publicado: (2014)

Nuclear localization of the tyrosine kinase BMX mediates VEGFR2 expression
por: Liu, Tingting, et al.
Publicado: (2019)

Tyrosine Kinase ETK/BMX Is Up-Regulated in Bladder Cancer and Predicts Poor Prognosis in Patients with Cystectomy
por: Guo, Shengjie, et al.
Publicado: (2011)

STAT3 Activation in Pressure-Overloaded Feline Myocardium: Role for Integrins and the Tyrosine Kinase BMX
por: Willey, Christopher D., et al.
Publicado: (2008)

Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK
por: Forster, Michael, et al.
Publicado: (2020)

BMX: Biological modelling and interface exchange
por: Palmer, Bruce J., et al.
Publicado: (2023)

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
por: Hu, Chi-Hao, et al.
Publicado: (2023)

BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors
por: Buelow, Daelynn R., et al.
Publicado: (2022)

Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors
por: Seixas, João D., et al.
Publicado: (2020)

A novel BMX variant promotes tumor cell growth and migration in lung adenocarcinoma
por: Wang, Ye, et al.
Publicado: (2017)

Power Analysis of Field-Based Bicycle Motor Cross (BMX)
por: Daneshfar, Amin, et al.
Publicado: (2020)

Novel Bruton’s tyrosine kinase inhibitors currently in development
por: D’Cruz, Osmond J, et al.
Publicado: (2013)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma
por: Chen, Chenglong, et al.
Publicado: (2022)

Metabolism-related pharmacokinetic drug−drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations
por: Teo, Yi Ling, et al.
Publicado: (2015)

Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma
por: Xu, Xiaofeng, et al.
Publicado: (2014)

Current understanding of the role of tyrosine kinase 2 signaling in immune responses
por: Muromoto, Ryuta, et al.
Publicado: (2022)

Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C.
Publicado: (2013)

Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes
por: Chang, Wei-Ting, et al.
Publicado: (2020)

BMX: a tool for computing bacterial phyletic composition from orthologous maps
por: Kulohoma, Benard W
Publicado: (2015)

Relationship between Cyclic and Non-Cyclic Force-Velocity Characteristics in BMX Cyclists
por: Gross, Micah, et al.
Publicado: (2019)

BMX controls 3βHSD1 and sex steroid biosynthesis in cancer
por: Li, Xiuxiu, et al.
Publicado: (2023)

A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation
por: Ferguson, Gregory D., et al.
Publicado: (2016)

Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
por: Bhargava, Pankaj, et al.
Publicado: (2011)

The Influence of BMX Gene Polymorphisms on Clinical Symptoms after Mild Traumatic Brain Injury
por: Wang, Yu-Jia, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors and Pregnancy
por: Abruzzese, Elisabetta, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Nanomedicine of tyrosine kinase inhibitors
por: Smidova, Veronika, et al.
Publicado: (2021)

NBM-T-L-BMX-OS01, Semisynthesized from Osthole, Is a Novel Inhibitor of Histone Deacetylase and Enhances Learning and Memory in Rats
por: Yang, Ying-Chen, et al.
Publicado: (2013)

Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in bmx model mice
por: McCormack, Nikki M., et al.
Publicado: (2023)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

Inhibition of Bruton's Tyrosine Kinase Protects Against Burn Sepsis-Induced Intestinal Injury
por: Wan, Jia, et al.
Publicado: (2022)

Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
por: Li, Xin, et al.
Publicado: (2018)

Second-generation inhibitors of Bruton tyrosine kinase
por: Wu, Jingjing, et al.
Publicado: (2016)

Latest progress in tyrosine kinase inhibitors
por: Pospelova, Tatiana V., et al.
Publicado: (2014)

Tyrosine kinase inhibitors in sarcoma treatment
por: Kyriazoglou, Anastasios, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
por: Kockerols, Camille C.B., et al.
Publicado: (2022)

A Scoping Review on Tyrosine Kinase Inhibitors in Cats: Current Evidence and Future Directions
por: Žagar, Žiga, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eq69nshc1ou11i96o37hj4c9dp